Bigul

Ortin Laboratories Ltd - 539287 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter And Half-Year Ended 30.09.2021.

Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 ,inter alia, to consider and approve Unaudited financial results for the quarter and half-year ended 30.09.2021.
05-11-2021
Bigul

Ortin Laboratories Ltd - 539287 - Shareholding for the Period Ended September 30, 2021

Ortin Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
20-10-2021
Bigul

Ortin Laboratories Ltd - 539287 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for quarter ended 30.09.2021
20-10-2021
Bigul

Ortin Laboratories Ltd - 539287 - Statement Of Investor Complaints For The Quarter Ended September 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- S Murali Krishna MurthyDesignation :- Managing Director / Whole Time Director
20-10-2021
Bigul

Ortin Laboratories Ltd - 539287 - Extension Of Annual General Meeting

Extension of Annual general meeting
14-09-2021
Bigul

Ortin Laboratories Ltd - 539287 - Outcome of Board Meeting (AGM on Sept 30, 2021)

Ortin Laboratories Ltd has informed BSE regarding Outcome of Board Meeting held on August 14, 2021.
14-08-2021
Bigul

Ortin Laboratories Ltd - 539287 - Unaudited Financial Results For The Quarter Ended 30.06.2021

Unaudited financial results for the quarter ended 30.06.2021
14-08-2021
Bigul

Ortin Laboratories Ltd - 539287 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30.06.2021

Ortin Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 ,inter alia, to consider and approve Unaudited financial results for the quarter ended 30.06.2021
02-08-2021
Next Page
Close

Let's Open Free Demat Account